Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Malaria Test Assessed in Nonendemic Setting

By LabMedica International staff writers
Posted on 23 May 2011
A rapid diagnostic test (RDT) for malaria has been evaluated in a standard reference laboratory using stored and fresh blood samples. More...


In nonendemic settings, where microscopic expertise is lacking due to low incidence, malaria RDTs are of value for the diagnosis of malaria and they provide information about the possibly fatal Plasmodium falciparum infections.

Scientists at Maastricht University, (Maastricht, The Netherlands), performed both a retrospective study on 341 stored blood samples and prospective study. In the prospective study, the SD Bioline Malaria Ag 05FK40, (SDFK40), RDT was used on 181 fresh samples and run side by side with two other RDTs, OptiMAL and SDFK60. The SDFK40 is a lateral flow antigen-detection test in a cassette format, targeting P. falciparum-specific parasite lactate dehydrogenase (Pf-pLDH) and pan-Plasmodium LDH, (pan-pLDH). The prospective part was performed between March 2009 and October 2010, and included first samples of each patient for which microscopy or one of the both routinely used RDTs (OptiMAL and SDFK60) were positive for malaria.

Overall sensitivities for P. falciparum tested retrospectively and prospectively were 67.9% and 78.8%, reaching 100% and 94.6% at parasite densities greater than 1,000/μL. Sensitivity at parasite densities less than 100/μL was 9.1%. Overall sensitivities for P. vivax and P. ovale were 86.7% and 80.0% (retrospectively) and 92.9% and 76.9% (prospectively), reaching 94.7% for both species (retrospective panel) at parasite densities greater than 500/μL. Sensitivity for P. malariae was 21.4%. None of the Plasmodium negative samples in the retrospective panel reacted positive.

The authors concluded that SDFK40 RDT (Standard Diagnostics Inc.; Suwon, Korea), performed exceptionally for P. falciparum samples at high parasite densities as well as for detection of P. vivax and P. ovale at parasite densities greater than 500/μL. The SDFK40 was evaluated as easy to use, with an excellent clearance of the background and clearly visible test lines. Compared to OptiMAL Rapid Malaria test, (Diamed AG; Cressier, Switzerland), and Standard Diagnostics other RDT, called SD Bioline Ag Pf/Pan 05FK60 (SDFK60), SDFK40 showed lower sensitivities for P. falciparum, but better detection of P. ovale. The study was published online on January 12, 2011, in the Malaria Journal.

Related Links:
Maastricht University
Standard Diagnostics Inc.
Diamed AG



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.